Yun Shin Chun, MD, FACS

Peer-Reviewed Articles

1. Piliposyan M, Peoples JJ, Hamghalam M, Mojtahedi R, Kobayashi K, Bunker EC, Gangai N, Kang HC, Chun YS, Muise C, Do RKG, Simpson AL. Radiomic signatures from baseline CT predict chemotherapy response in unresectable colorectal liver metastases. J Med Imaging (Bellingham) 13(1):014505, 2026. e-Pub 2026. PMID: 41536565.
2. Piliposyan M, Peoples JJ, Hamghalam M, Mojtahedi R, Kobayashi RK, Bunker EC, Gangai N, Kang HC, Chun YS, Muise C, Do RK, Simpson AL. Radiomic signatures from baseline CT predict chemotherapy response in unresectable colorectal liver metastases. J Med Imaging, 2026.
3. Folkert IW, Chun YS. ASO Author Reflections: Hepatectomy May Improve Survival in Patients with Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma: Results from the LUNA Trial. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 41460626.
4. De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Tran Cao HS, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. NPJ Syst Biol Appl 11(1):140, 2025. e-Pub 2025. PMID: 41387975.
5. Folkert IW, Mehran R, Sun R, Morris VK, Overman MJ, Kee B, Antonoff MB, Tzeng CW, Dasari A, Tran Cao H, Parseghian CM, Vilar E, Willis J, Newhook TE, Hofstetter W, Kopetz SE, Vauthey JN, Chun YS. Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 41369813.
6. Wang X, Haro-Silerio JI, Beaudry FEG, Borgida A, Abbas-Aghababazadeh F, Sahebi NB, Wang M, Fox DA, Nuh M, Hsiang M, Bhamidipati D, Kang HC, Cox V, Ludmir E, Koay E, Kwong L, Quentin K, Chatterjee D, Chun YS, Cao HT, Meric-Bernstam F, Hu I, Dodd A, Hamza O, Hildebrand M, Bucur R, Hirschfield GM, Vogel A, O'Kane GM, Gallinger S, Haibe-Kains B, Notta F, Sapisochin G, Knox J, Javle MM, Lee SS, Grant R. Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract Cancers. Clin Cancer Res, 2025. e-Pub 2025. PMID: 41252561.
7. Eid J, Haddad A, Hassan M, Amin HM, Newhook TE, Chun YS, Tzeng CD, Vauthey JN, Cao HST, Kaseb AO. Evaluating the Role of Preoperative Serum Insulin-like Growth Factor I (IGF-I) as a Predictor of Survival and Recurrence for Patients with Resectable Hepatocellular Carcinoma. J Gastrointest Surg:102275, 2025. e-Pub 2025. PMID: 41197829.
8. Folkert IW, Mehran R, Sun R, Morris VK, Overman MJ, Kee B, Antonoff MB, Tzeng CW, Dasari A, Tran Cao H, Parseghian CM, Vilar E, Willis J, Newhook TE, Hofstetter W, Kopetz SE, Vauthey JN, Chun YS. Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial. Ann Surg Oncol. e-Pub 2025.
9. Han Y, Shaw VR, Byun J, Thrift AP, Zhu C, Li D, Hatia RI, Kelley RK, Cleary SP, Lok AS, Bracci PM, Permuth JB, Bucur R, Knox J, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Kono Y, Shah DP, Nguyen MH, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Chun YS, Gu J, Huff C, Rashid A, Hwang LY, Klein AP, Khaderi SA, Kaseb AO, McGlynn KA, Roberts LR, Hassan MM, Amos CI. Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits. Int J Cancer, 2025. e-Pub 2025. PMID: 41013983.
10. Acidi B, Haddad A, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Advancing Robotic Liver Resection: The Sling Technique for Improved Hepatic Retraction. Ann Surg Oncol 32(7):5021, 2025. e-Pub 2025. PMID: 40126718.
11. Lendoire M, Maki H, Haddad A, Jain AJ, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Newhook TE. Parenchymal-sparing hepatectomy vs single-stage major hepatectomy for bilateral colorectal liver metastases: a higher rate of microscopically positive margins is not associated with increased local recurrence after parenchymal-sparing hepatectomy. J Gastrointest Surg 29(7):102070, 2025. e-Pub 2025. PMID: 40280465.
12. Jain AJ, Lendoire M, Haddad A, Tzeng CD, Boyev A, Maki H, Chun YS, Arvide EM, Lee S, Hu I, Pant S, Javle M, Tran Cao HS, Vauthey JN, Newhook TE. Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience. Ann Surg Oncol 32(6):4352-4362, 2025. e-Pub 2025. PMID: 40000564.
13. Serenari M, Berti D, Rivera B, Newhook TE, Kristjanpoller W, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OM, Munoz C, Denbo J, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Anaya DA, Torzilli G, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN, Cescon M, Vega EA. Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-center Study. Ann Surg Oncol 32(6):4374-4382, 2025. e-Pub 2025. PMID: 40050485.
14. Odisio BC, Albuquerque J, Lin YM, Anderson BM, O'Connor CS, Rigaud B, Briones-Dimayuga M, Jones AK, Fellman BM, Huang SY, Kuban J, Metwalli ZA, Sheth R, Habibollahi P, Patel M, Shah KY, Cox VL, Kang HC, Morris VK, Kopetz S, Javle MM, Kaseb A, Tzeng CW, Cao HT, Newhook T, Chun YS, Vauthey JN, Gupta S, Paolucci I, Brock KK. Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial. Lancet Gastroenterol Hepatol 10(5):442-451, 2025. e-Pub 2025. PMID: 40090348.
15. Maki H, Ayabe RI, Haddad A, Nishioka Y, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN. Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol 32(4):2425-2434, 2025. e-Pub 2025. PMID: 39821490.
16. Seo YD, Acidi B, Newton A, Haddad A, Chiang YJ, Coelho R, Newhook TE, Tzeng CD, Chun YS, Ludmir EB, Koay EJ, Javle M, Vauthey JN, Cao HST. Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched Analysis. Cancers (Basel) 17(3), 2025. e-Pub 2025. PMID: 39941861.
17. Haddad A, Lendoire M, Uppal A, Maki H, Folkert I, Wang Y, Ayabe RI, Newhook TE, Chun YS, Tzeng CD, Vauthey JN, Tran Cao HS. CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol 32(2):1021-1032, 2025. e-Pub 2025. PMID: 39516416.
18. Landry J, Jain AJ, Tzeng CW, Newhook TE, Ikoma N, Chun YS, Vauthey JN, Cheah YL, Hawksworth JS, Tran Cao HS. Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools. Ann Surg Oncol 32(1):438-439, 2025. e-Pub 2025. PMID: 39414702.
19. Peoples JJ, Hamghalam M, James I, Wasim M, Gangai N, Kang HC, Rong XJ, Chun YS, Do RKG, Simpson AL. Finding Reproducible and Prognostic Radiomic Features in Variable Slice Thickness Contrast Enhanced CT of Colorectal Liver Metastases. J Mach Learn Biomed Imaging 2(UNSURE2023):2326-2357, 2025. e-Pub 2025. PMID: 41394427.
20. Hatia RI, Hwang LY, Li R, Troisi C, Jalal PK, Amos CI, Gomez HF, Chun YS, Rashid A, Kaseb AO, Scheet PA, Hassan MM. Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus. J Hepatocell Carcinoma 12:93-106, 2025. e-Pub 2025. PMID: 39867264.
21. De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Cao HST, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. NPJ Systems Biology and Applications, 2024. e-Pub 2024. PMID: 39314943.
22. Azimuddin AM, Hirata Y, Boyev A, Jain AJ, Ayabe R, Ajith J, Schmeisser JA, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. A propensity score matched cost analysis of robotic versus open hepatectomy. HPB (Oxford), 2024. e-Pub 2024. PMID: 39198140.
23. Hassan MM, Li D, Han Y, Byun J, Hatia RI, Long E, Choi J, Kelley RK, Cleary SP, Lok AS, Bracci P, Permuth JB, Bucur R, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Santella RM, Kono Y, Shah DP, Nguyen MH, Liu G, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Li Y, Chun YS, Lee SS, Gu J, Hawk E, Sun R, Huff C, Rashid A, Amin HM, Beretta L, Wolff RA, Antwi SO, Patt Y, Hwang LY, Klein AP, Zhang K, Schmidt MA, White DL, Goss JA, Khaderi SA, Marrero JA, Cigarroa FG, Shah PK, Kaseb AO, Roberts LR, Amos CI. Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology 80(1):87-101, 2024. e-Pub 2024. PMID: 38381705.
24. Maki H, Nishioka Y, Haddad A, Lendoire M, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Newhook TE. Reproducibility and efficiency of liver volumetry using manual method and liver analysis software. HPB (Oxford) 26(7):911-918, 2024. e-Pub 2024. PMID: 38632032.
25. Martin AN, Newhook TE, Arvide EM, Kim BJ, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Chun YS, Katz MH, Vauthey JN, Tzeng CD. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg 233:17-23, 2024. e-Pub 2024. PMID: 38129274.
26. Tran Cao HS, Witt RG, Elsayes KM, Baiomy AA, Xiao L, Palmquist S, Lee SS, Mohamed YI, Mahvash A, Tzeng CD, Chun YS, Koay EJ, Rashid A, Hassan MM, Yao JC, Vauthey JN, Kaseb AO. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist 29(6):e803-e810, 2024. e-Pub 2024. PMID: 38159256.
27. Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CD, Tran Cao HS, Coronel E, Lee SS, Hu ZI, Javle M, Lee JH, Vauthey JN, Chun YS. Revisiting the Malignant Masquerade at the Liver Hilum: Have We Made Progress?. Ann Surg Oncol 31(5):3062-3068, 2024. e-Pub 2024. PMID: 38282027.
28. Jain AJ, Chun YS. ASO Author Reflections: Hilar Biliary Strictures-A Persistent Diagnostic and Management Dilemma. Ann Surg Oncol 31(5):3112-3113, 2024. e-Pub 2024. PMID: 38363471.
29. Boyev A, Tzeng CD, Maki H, Arvide EM, Mrema DE, Jain AJ, Haddad A, Lendoire M, Malik N, Odisio BC, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Local Therapy Improves Survival for Early Recurrence After Resection of Colorectal Liver Metastases. Ann Surg Oncol 31(4):2547-2556, 2024. e-Pub 2024. PMID: 38148351.
30. Jain AJ, Newhook TE, Lilley E, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol 31(3):1833, 2024. e-Pub 2024. PMID: 37989954.
31. Swords DS, Newhook TE, Tzeng CD, Massarweh NN, Chun YS, Lee S, Kaseb AO, Ghobrial M, Vauthey JN, Tran Cao HS. ASO Visual Abstract: Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. e-Pub 2023. PMID: 37782416.
32. Swords DS, Newhook TE, Tzeng CD, Massarweh NN, Chun YS, Lee S, Kaseb AO, Ghobrial M, Vauthey JN, Tran Cao HS. Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. e-Pub 2023. PMID: 37679537.
33. Maki H, Kim BJ, Kawaguchi Y, Fernandez-Placencia R, Haddad A, Panettieri E, Newhook TE, Baumann DP, Santos D, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Vreeland TJ. Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases. J Gastrointest Surg. e-Pub 2023. PMID: 37537494.
34. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. ASO Visual Abstract: Hepatectomy Before Primary Tumor Resection as the Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. e-Pub 2023. PMID: 37358681.
35. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. e-Pub 2023. PMID: 37344750.
36. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. e-Pub 2023. PMID: 37322282.
37. Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Hepatectomy before primary tumor resection as preferred approach for synchronous liver metastases from rectal cancer. Ann Surg Oncol. e-Pub 2023. PMID: 37285096.
38. Vega EA, Newhook TE, Mellado S, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, Rojas J, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OA, Munoz C, Denbo JW, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Torzilli G, Giuliante F, Anaya DA, Guglielmi A, Vinuela E, Vauthey JN. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multi-Center Study. Ann Surg Oncol. e-Pub 2023. PMID: 37149547.
39. Maki H, Jain AJ, Haddad A, Lendoire M, Chun YS, Vauthey JN. Locoregional treatment for colorectal liver metastases aiming for precision medicine. Ann Gastroenterol Surg 7(4):543-552, 2023. e-Pub 2023.
40. Kothari AN, Massarweh NN, Flitcroft MA, Newhook T, Tzeng CD, Chun YS, Kaseb AO, Vauthey JN, Tran Cao HS. Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). e-Pub 2023. PMID: 37085394.
41. Martin AN, Tzeng CD, Arvide EM, Skibber JM, Chang GJ, Nancy You YQ, Bednarski BK, Uppal A, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). e-Pub 2023. PMID: 36697350.
42. Ayabe RI, Paez-Arango N, Estrella JS, Newhook TE, Tzeng CD, Chun YS, Lee S, Javle M, Vauthey JN, Tran Cao HS. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?. HPB (Oxford). e-Pub 2023. PMID: 36781357.
43. Morris VK, Overman MJ, Lam M, Parseghian CM, Johnson B, Dasari A, Raghav K, Kee BK, Huey R, Wolff RA, Shen JP, Li J, Zorrilla I, Tzeng CD, Tran Cao HS, Chun YS, Newhook TE, Vauthey N, Duose D, Luthra R, Haymaker C, Kopetz S. Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Res Commun 2(9):979-986, 2022. e-Pub 2022. PMID: 36382087.
44. Kim BJ, Newhook TE, Tzeng CD, Ikoma N, Chiang YJ, Chun YS, Vauthey JN, Tran Cao HS. Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol 126(4):658-666, 2022. e-Pub 2022. PMID: 35578764.
45. Panettieri E, Kim BJ, Kawaguchi Y, Ardito F, Mele C, De Rose AM, Vellone M, Chun YS, Tzeng CD, Aloia TA, Giuliante F, Vauthey JN. Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases. J Gastrointest Surg. e-Pub 2022. PMID: 36127553.
46. Newton AD, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Robotic Extended Right Hepatectomy for Colorectal Liver Metastasis. Ann Surg Oncol. e-Pub 2022. PMID: 36112251.
47. Lillemoe HA, Passot G, Kawaguchi Y, DeBellis M, Glehen O, Chun YS, Tzeng CD, Aloia TA, Lopez J, Vauthey JN. RAS/TP53 co-mutation is associated with worse survival after concurrent resection of colorectal liver metastases and extrahepatic disease. Ann Surg 276(2):357-362, 2022. e-Pub 2022. PMID: 33351476.
48. Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Outcomes of mixed pathologic response in patients with multiple colorectal liver metastases treated with neoadjuvant chemotherapy and liver resection. Ann Surg Oncol 29(8):5156-5164, 2022. e-Pub 2022. PMID: 35397746.
49. Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Katz MHG. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. e-Pub 2022. PMID: 35950790.
50. Chun YS, Passot G, Nishioka Y, Katkhuda R, Arvide EM, Benzerdjeb N, Lopez J, Kopetz SE, Maru DM, Vauthey JN. Colorectal liver micrometastases: association with RAS/TP53 co-mutation and prognosis after surgery. J Am Coll Surg 235(1):8-16, 2022. e-Pub 2022. PMID: 35703957.
51. Kim BJ, Arvide EM, Gaskill C, Martin AN, Kawaguchi Y, Chiang YJ, Dewhurst WL, Phan TL, Tran Cao HS, Chun YS, Katz MHG, Vauthey JN, Tzeng CD, Newhook TE. Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surg Open Sci 9:109-116, 2022. e-Pub 2022. PMID: 35747509.
52. Newhook TE, Overman MJ, Chun YS, Dasari A, Tzeng CD, Cao HST, Raymond V, Parseghian C, Johnson B, Nishioka Y, Kawaguchi Y, Uppal A, Vreeland TJ, Jaimovich A, Arvide EM, Cristo JV, Wei SH, Raghav KP, Morris VK, Lee JE, Kopetz S, Vauthey JN. Prospective study of perioperative circulating tumor DNA dynamics in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. e-Pub 2022. PMID: 35797554.
53. DiPeri TP, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CD. Prospective implementation of standardized post-hepatectomy care pathways to reduce opioid prescription volume after inpatient surgery. J Am Coll Surg 235(1):41-48, 2022. e-Pub 2022. PMID: 35703961.
54. Nishioka Y, Paez-Arango N, Boettcher FO, Kawaguchi Y, Newhook TE, Chun YS, Tzeng CD, Tran Cao HS, Lee JE, Vreeland TJ, Vauthey JN. Neither surgical margin status nor somatic mutation predicts local recurrence after R0-intent resection for colorectal liver metastases. J Gastrointest Surg 26(4):791-801, 2022. e-Pub 2022. PMID: 34725784.
55. Nishioka Y, Chun YS, Overman MJ, Cao HST, Tzeng CD, Mason MC, Kopetz SW, Bauer TW, Vauthey JN, Newhook TE, MD Anderson Cancer Center INTERCEPT Program MD. Effect of co-mutation of RAS and TP53 on postoperative ctDNA detection and early recurrence after hepatectomy for colorectal liver metastases. J Am Coll Surg 234(4):474-483, 2022. e-Pub 2022. PMID: 35290266.
56. Lee SH, Yim SY, Jeong YS, Li QX, Kang SH, Sohn BH, Kumar SV, Shin JH, Choi YR, Shim JJ, Kim H, Kim J, Kim S, Guo S, Johnson RL, Kaseb A, Kang KJ, Chun YS, Jang HJ, Lee BG, Woo HG, Ha MJ, Akbani R, Roberts LR, Wheeler DA, Lee JS. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes. Hepatology. e-Pub 2022. PMID: 35349735.
57. Kawaguchi Y, Kopetz S, Panettieri E, Hwang H, Wang X, Cao HST, Tzeng CD, Chun YS, Aloia TA, Vauthey JN. Improved survival over time after resection of colorectal liver metastases and clinical impact of multigene alteration testing in patients with metastatic colorectal cancer. J Gastrointest Surg 26(3):583-593, 2022. e-Pub 2022. PMID: 34506029.
58. Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey JN, Lee SS, Yavuz BG, Mohamed YI, Qayyum A, Jindal S, Duan F, Basu S, Yadav SS, Nicholas C, Sun JJ, Singh Raghav KP, Rashid A, Carter K, Chun YS, Tzeng CD, Sakamuri D, Xu L, Sun R, Cristini V, Beretta L, Yao JC, Wolff RA, Allison JP, Sharma P. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol 7(3):208-218, 2022. e-Pub 2022. PMID: 35065057.
59. Lee SH, Jeong YS, Lee S, Sohn BH, Hwang HK, Choi GH, Kang CM, Choi JS, Lee WJ, Cheong JH, Jang HJ, Kaseb A, Roberts L, Yim SY, Chun YS, Lee JS. Two distinct stem cell-like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials. Cancer Commun (Lond) 42(2):179-183, 2022. e-Pub 2022. PMID: 35032367.
60. Zheng J, Daniel CR, Hatia RI, Stuff J, Abdelhakeem AA, Rashid A, Chun YS, Jalal PK, Kaseb AO, Li D, Hassan MM. Dietary N-nitroso compounds and risk of hepatocellular carcinoma: a USA-based study. Hepatology 74(6):3161-3173, 2021. e-Pub 2021. PMID: 34233041.
61. Moussa I, Day RS, Li R, Kaseb A, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Association of dietary fat intake and hepatocellular carcinoma among US adults. Cancer Med 10(20):7308-7319, 2021. e-Pub 2021. PMID: 34535983.
62. Newton AD, Newhook TE, Ikoma N, White MG, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Robotic completion radical cholecystectomy with fluorescence guidance. Ann Surg Oncol 28(11):6834, 2021. e-Pub 2021. PMID: 33774771.
63. Mason MC, Massarweh NN, Tzeng CD, Chiang YJ, Chun YS, Aloia TA, Javle M, Vauthey JN, Tran Cao HS. Time to rethink upfront surgery for resectable intrahepatic cholangiocarcinoma? Implications from the neoadjuvant experience. Ann Surg Oncol 28(11):6725-6735, 2021. e-Pub 2021. PMID: 33586068.
64. Khan TM, Verbus EA, Rehman SU, Chun YS, Hernandez JM. The role of liver resection for patients with liver and unresectable lung colorectal metastases (LUNA). Ann Surg Oncol 28(8):4102-4103, 2021. e-Pub 2021. PMID: 33987761.
65. Kawaguchi Y, Kopetz S, Tran Cao HS, Panettieri E, De Bellis M, Nishioka Y, Hwang H, Wang X, Tzeng CD, Chun YS, Aloia TA, Hasegawa K, Guglielmi A, Giuliante F, Vauthey JN. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg 108(8):968-975, 2021. e-Pub 2021. PMID: 33829254.
66. Kawaguchi Y, Kopetz S, Kwong L, Xiao L, Morris JS, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN. Genomic sequencing and insight into clinical heterogeneity and prognostic pathway genes in patients with metastatic colorectal cancer. J Am Coll Surg 233(2):272-284.e13, 2021. e-Pub 2021. PMID: 34111531.
67. Mason MC, Tzeng CD, Tran Cao HS, Aloia TA, Newhook TE, Overman MJ, Kopetz SE, Vauthey JN, Chun YS. Preliminary analysis of liquid biopsy after hepatectomy for colorectal liver metastases. J Am Coll Surg 233(1):82-89.e1, 2021. e-Pub 2021. PMID: 33667566.
68. Kanikarla Marie P, Haymaker C, Parra ER, Kim YU, Lazcano R, Gite S, Lorenzini D, Wistuba II, Tidwell RSS, Song X, Foo WC, Maru DM, Chun YS, Futreal A, Kee B, Menter D, Solis L, Tzeng CW, Parseghian C, Raghav K, Morris V, Chang CC, Jenq R, Tam A, Bernatchez C, Kopetz S, Vauthey JN, Overman MJ. Pilot clinical trial of perioperative durvalumab and tremelimumab in the treatment of resectable colorectal cancer liver metastases. Clin Cancer Res 27(11):3039-3049, 2021. e-Pub 2021. PMID: 33811152.
69. Moussa I, Day RS, Li R, Du XL, Kaseb AO, Jalal PK, Daniel-MacDougall C, Hatia RI, Abdelhakeem A, Rashid A, Chun YS, Li D, Hassan MM. Dietary patterns and hepatocellular carcinoma risk among US adults. Nutrients 13(6):2011, 2021. e-Pub 2021. PMID: 34208122.
70. Vega EA, Newhook TE, Kawaguchi Y, Qiao W, De Bellis M, Okuno M, Panettieri E, Nishino H, Duwe G, Piccino M, De Rose AM, Ruzzenente A, Uemoto S, Vivanco M, Chun YS, Cao HST, Tzeng CD, De Aretxabala X, Seo S, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN. Conditional recurrence-free survival after oncologic extended resection for gallbladder cancer: an international multicenter analysis. Ann Surg Oncol 28(5):2675-2682, 2021. e-Pub 2021. PMID: 33666814.
71. Lee SH, Simoneau EB, Karpinets T, Futreal PA, Zhang J, Javle M, Zhang J, Vauthey JN, Lee JS, Estrella JS, Chun YS. Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations. Carcinogenesis 42(3):436-441, 2021. e-Pub 2021. PMID: 33200197.
72. White MG, Tzeng CW, Ikoma N, Chun YS, Aloia TA, Vauthey JN, Cao HST. Robotic partial segment VIII resection. Ann Surg Oncol 28(3):1513, 2021. e-Pub 2021. PMID: 32761429.
73. Denbo JW, Kim BJ, Vauthey JN, Tzeng CW, Ma J, Huang SY, Chun YS, Katz MHG, Aloia TA. Overall body composition and sarcopenia are associated with poor liver hypertrophy following portal vein embolization. J Gastrointest Surg 25(2):405-410, 2021. e-Pub 2021. PMID: 31997073.
74. Kawaguchi Y, Newhook TE, Tran Cao HS, Tzeng CD, Chun YS, Aloia TA, Dasari A, Kopetz S, Vauthey JN. Alteration of FBXW7 is associated with worse survival in patients undergoing resection of colorectal liver metastases. J Gastrointest Surg 25(1):186-194, 2021. e-Pub 2021. PMID: 33205306.
75. Yamashita S, Chun YS, Kopetz SE, Maru D, Conrad C, Aloia TA, Vauthey JN. APC and PIK3CA mutational cooperativity predicts pathologic response and survival in patients undergoing resection for colorectal liver metastases. Ann Surg 272(6):1080-1085, 2020. e-Pub 2020. PMID: 28379870.
76. Kawaguchi Y, Kopetz S, Lillemoe HA, Hwang H, Wang X, Tzeng CD, Chun YS, Aloia TA, Vauthey JN. A new surveillance algorithm after resection of colorectal liver metastases based on changes in recurrence risk and RAS mutation status. J Natl Compr Canc Netw 18(11):1500-1508, 2020. e-Pub 2020. PMID: 33152698.
77. Chun YS, Mizuno T, Cloyd JM, Ha MJ, Omichi K, Tzeng CD, Aloia TA, Ueno NT, Kuerer HM, Barcenas CH, Vauthey JN. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol 46(9):1588-1595, 2020. e-Pub 2020. PMID: 32253074.
78. Joechle K, Vreeland TJ, Vega EA, Okuno M, Newhook TE, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Lee JE, Vauthey JN. Anatomic resection is not required for colorectal liver metastases with RAS mutation. J Gastrointest Surg 24(5):1033-1039, 2020. e-Pub 2020. PMID: 32162236.
79. Okuno M, Newhook TE, Joechle K, Kawaguchi Y, De Bellis M, Tzeng CD, Chun YS, Aloia TA, Shindoh J, Kaseb AO, Vauthey JN. Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?. HPB (Oxford) 22(4):545-552, 2020. e-Pub 2020. PMID: 31533893.
80. Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN. Comprehensive complication index validates improved outcomes over time despite increased complexity in 3707 consecutive hepatectomies. Ann Surg 271(4):724-731, 2020. e-Pub 2020. PMID: 30339628.
81. Kawaguchi Y, Hasegawa K, Tzeng CD, Mizuno T, Arita J, Sakamoto Y, Chun YS, Aloia TA, Kokudo N, Vauthey JN. Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity. Br J Surg 107(3):258-67, 2020. e-Pub 2020. PMID: 31603540.
82. Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN. Surgical management of localized hepatocellular carcinoma in times of crisis: a strategic approach to resource utilization. J Hepatocell Carcinoma 7:155-158, 2020. e-Pub 2020. PMID: 33062624.
83. Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of integrating insulin-like growth factor 1 levels into model for end-stage liver disease score for survival prediction in hepatocellular carcinoma patients. Oncology 98(12):836-846, 2020. e-Pub 2020. PMID: 33027788.
84. Goffredo P, Utria AF, Beck AC, Chun YS, Howe JR, Weigel RJ, Vauthey JN, Hassan I. The prognostic impact of KRAS mutation in patients having curative resection of synchronous colorectal liver metastases. J Gastrointest Surg 23(10):1957-1963, 2019. e-Pub 2019. PMID: 30276588.
85. Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of RAS alone for predicting prognosis after resection of colorectal liver metastases. Clin Cancer Res 25(19):5843-5851, 2019. e-Pub 2019. PMID: 31221662.
86. Kawaguchi Y, Lillemoe HA, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Kopetz S, Vauthey JN. Conditional recurrence-free survival after resection of colorectal liver metastases: persistent deleterious association with RAS and TP53 co-mutation. J Am Coll Surg 229(3):286-294.e1, 2019. e-Pub 2019. PMID: 31054911.
87. Vreeland TJ, Beaudry Simoneau E, Dewhurst WL, Newhook TE, Westin SN, Mehran RJ, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Intraoperative air leak test to prevent bile leak after right posterior sectionectomy with en bloc diaphragm resection for metastatic teratoma. Ann Surg Oncol 26(8):2579, 2019. e-Pub 2019. PMID: 31065963.
88. Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, Jarufe N, Martinez J, Troncoso A, Diaz A, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB 21(8):1046-56, 2019. e-Pub 2019.
89. Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, Jarufe N, Martinez J, Troncoso A, Diaz A, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB (Oxford) 21(8):1046-1056, 2019. e-Pub 2019. PMID: 30711243.
90. Wiseman JT, Guzman-Pruneda F, Xourafas D, Chun YS, Ejaz A, Tsung A, Pawlik TM, Cloyd JM. Impact of Neoadjuvant Chemotherapy on the Postoperative Outcomes of Patients Undergoing Liver Resection for Colorectal Liver Metastases: A Population-Based Propensity-Matched Analysis. J Am Coll Surg 229(1):69-77.e2, 2019. e-Pub 2019. PMID: 30905856.
91. Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg 218(1):145-150, 2019. e-Pub 2019. PMID: 30224070.
92. Wiseman JT, Guzman-Pruneda F, Xourafas D, Chun YS, Ejaz A, Tsung A, Pawlik TM, Cloyd JM. Impact of neoadjuvant chemotherapy on the postoperative outcomes of patients undergoing liver resection for colorectal liver metastases: a population-based propensity-matched analysis. J Am Coll Surg 229(1):69-77, 2019. e-Pub 2019.
93. Vega EA, Vinuela E, Sanhueza M, Mege R, Caracci M, Diaz C, Diaz A, Okuno M, Joechle K, Goumard C, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. Eur J Surg Oncol 45(6):1061-1068, 2019. e-Pub 2019. PMID: 30704808.
94. Chun YS, Passot G, Yamashita S, Nusrat M, Katsonis P, Loree JM, Conrad C, Tzeng CD, Xiao L, Aloia TA, Eng C, Kopetz SE, Lichtarge O, Vauthey JN. Deleterious effect of RAS and evolutionary high-risk TP53 double mutation in colorectal liver metastases. Ann Surg 269(5):917-23, 2019. e-Pub 2019. PMID: 28767562.
95. Joechle K, Goumard C, Vega EA, Okuno M, Chun YS, Tzeng CD, Vauthey JN, Conrad C. Long-term survival after post-hepatectomy liver failure for colorectal liver metastases. HPB (Oxford) 21(3):361-369, 2019. e-Pub 2019. PMID: 30100391.
96. Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD. Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma. Ann Surg Oncol 26(2):652, 2019. e-Pub 2019. PMID: 30539487.
97. Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Conrad C, Kim MP, Katz M, Tzeng CW. Pancreaticoduodenectomy with mesocaval shunt for locally advanced pancreatic adenocarcinoma. Ann Surg Oncol (Video-Manuscript) 26(2):652, 2019. e-Pub 2019.
98. Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S. Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. Br J Cancer 120(3):340-345, 2019. e-Pub 2019.
99. Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA, Conrad C. Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery 165(2):329-336, 2019. e-Pub 2019. PMID: 30197278.
100. Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S. Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. Br J Cancer 120(3):340-345, 2019. e-Pub 2019. PMID: 30636774.
101. Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CWD, Lee JE, Vauthey JN, Conrad C. Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy. HPB (Oxford) 21(1):43-50, 2019. e-Pub 2019. PMID: 30266496.
102. Vicente D, Patino M, Marcus R, Lillemoe H, Limani P, Newhook T, Lee A, Tzeng CW, Chun YS, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JP. Impact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget 10(5):584-94, 2019. e-Pub 2019.
103. Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy. Ann Surg Oncol 26(1):296, 2019. e-Pub 2019. PMID: 30465224.
104. Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS. Intrahepatic recurrence patterns predict survival after resection of colorectal liver metastases. Ann Surg Oncol 26(1):275-281, 2019. e-Pub 2019. PMID: 30362064.
105. Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Middle hepatic vein roadmap for a safe laparoscopic right hepatectomy. Ann Surg Oncol 26(1):296, 2019. e-Pub 2019.
106. Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Surgical resection for recurrence after two-stage hepatectomy for colorectal liver metastases is feasible, is safe, and improves survival. J Gastrointest Surg 23(1):84-92, 2019. e-Pub 2019. PMID: 30084064.
107. Goumard C, Nancy You Y, Okuno M, Kutlu O, Chen HC, Simoneau E, Vega EA, Chun YS, David Tzeng C, Eng C, Vauthey JN, Conrad C. Minimally invasive management of the entire treatment sequence in patients with stage IV colorectal cancer: a propensity-score weighting analysis. HPB (Oxford) 20(12):1150-1156, 2018. e-Pub 2018. PMID: 30005993.
108. Lee AJ, Chiang YJ, Lee JE, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines. J Surg Res 230:148-154, 2018. e-Pub 2018. PMID: 30100032.
109. Okuno M, Goumard C, Mizuno T, Kopetz S, Omichi K, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Conrad C. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases. Br J Surg 105(9):1200-1209, 2018. e-Pub 2018. PMID: 29664996.
110. Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A. Preoperative fluorouracil, doxorubicin, and streptozocin for the treatment of pancreatic neuroendocrine liver metastases. Ann Surg Oncol 25(6):1709-1715, 2018. e-Pub 2018.
111. Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A. Preoperative Fluorouracil, Doxorubicin, and Streptozocin for the Treatment of Pancreatic Neuroendocrine Liver Metastases. Ann Surg Oncol 25(6):1709-1715, 2018. e-Pub 2018. PMID: 29626307.
112. Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Omichi K, Tzeng CD, Chun YS, Vauthey JN, Conrad C. RAS mutation is associated with unsalvageable recurrence following hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 25(8):2457-2466. e-Pub 2018. PMID: 29786130.
113. Okuno M, Goumard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Aloia TA, Fleming JB, Lee JE, Vauthey JN, Conrad C. Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc 32(4):1776-1786, 2018. e-Pub 2018. PMID: 28917012.
114. Cloyd JM, Chun YS, Ikoma N, Vauthey JN, Aloia TA, Cuddy A, Rodriguez-Bigas MA, Nancy You Y. Clinical and genetic implications of DNA mismatch repair deficiency in biliary tract cancers associated with lynch syndrome. J Gastrointest Cancer 49(1):93-96, 2018. e-Pub 2018. PMID: 29238914.
115. Odisio BC, Yamashita S, Huang SY, Kopetz SE, Ahrar K, Mizuno T, Conrad C, Aloia TA, Chun YS, Gupta S, Vauthey JN. Impact of Prior Hepatectomy History on Local Tumor Progression after Percutaneous Ablation of Colorectal Liver Metastases. J Vasc Interv Radiol 29(3):395-403.e1, 2018. e-Pub 2018. PMID: 29395898.
116. Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN. Embryonic origin of primary colon cancer predicts pathologic response and survival in patients undergoing resection for colon cancer liver metastases. Ann Surg 267(3):514-520, 2018. e-Pub 2018. PMID: 28002060.
117. Yamashita S, Chun YS, Kopetz SE, Vauthey JN. Biomarkers in colorectal liver metastases. Br J Surg 105(6):618-627. e-Pub 2018. PMID: 29579319.
118. Odisio BC, Yamashita S, Huang SY, Kopetz SE, Ahrar K, Mizuno T, Conrad C, Aloia TA, Chun YS, Gupta S, Vauthey JN. Impact of prior hepatectomy history on local tumor progression after percutaneous ablation of colorectal liver metastases. J Vasc Interv Radiol 29(3):395-403, 2018. e-Pub 2018.
119. Mizuno T, Cloyd JM, Vicente D, Omichi K, Chun YS, Kopetz SE, Maru D, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JN. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol 44(5):684-692. e-Pub 2018. PMID: 29551247.
120. Mizuno T, Cloyd JM, Omichi K, Chun YS, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JN. Two-Stage hepatectomy vs one-stage major hepatectomy with contralateral resection or ablation for advanced bilobar colorectal liver metastases. J Am Coll Surg 226(5):825-834. e-Pub 2018. PMID: 29454099.
121. Passot G, Kim BJ, Glehen O, Mehran RJ, Kopetz SE, Goere D, Overman MJ, Pocard M, Marchal F, Conrad C, Aloia TA, Vauthey JN, Chun YS, Group BW. Impact of RAS mutations in metastatic colorectal cancer after potentially curative resection: Does site of metastases matter?. Ann Surg Oncol 25(1):179-187, 2018. e-Pub 2018. PMID: 29071660.
122. Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CD, Vauthey JN. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol 44(1):122-129, 2018. e-Pub 2018.
123. Okuno M, Gourmard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Conrad C. Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival. HPB (Oxford) 20(1):57-63, 2018. e-Pub 2018.
124. Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CD, Chun YS, Feig BW, Vauthey JN, Conrad C. Long-term survival according to histology and radiologic response to preoperative chemotherapy in 126 patients undergoing resection of non-GIST sarcoma liver metastases. Ann Surg Oncol 25(1):107-116, 2018. e-Pub 2018. PMID: 29116489.
125. Okuno M, Gourmard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Conrad C. Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival. HPB (Oxford) 20(1):57-63, 2018. e-Pub 2018. PMID: 28943395.
126. Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CD, Vauthey JN. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol 44(1):122-129, 2018. e-Pub 2018. PMID: 29208318.
127. Vega EA, Vinuela E, Yamashita S, Sanhueza M, Cavada G, Diaz C, Aloia TA, Chun YS Tzeng CD, Okuno M, Goumard C, Vauthey JN, Lee JE, Conrad C. Extended lymphadenectomy is required for incidental gallbladder cancer independent of cystic duct lymph node status. J Gastrointest Surg 22(1):43-51, 2018. e-Pub 2018. PMID: 28752405.
128. Omichi K, Yamashita S, Cloyd JM, Shindoh J; Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN, Tzeng CWD. Portal vein embolization reduces postoperative hepatic insufficiency associated with post-chemotherapy hepatic atrophy. J Gastrointest Surg 22(1):60-67, 2018. e-Pub 2018. PMID: 28585106.
129. Yamashita S, Sheth RA, Niekamp AS, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status. Ann Surg 266(6):1045-1054, 2017. e-Pub 2017. PMID: 27735824.
130. Omichi K, Mizuno T, Okuno M, Tzeng CD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Long term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol 43(11):2129-2134, 2017. e-Pub 2017. PMID: 28958732.
131. Omichi K, Cloyd JM, Yamashita S, Tzeng CWD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Neutrophil-to-lymphocyte ratio predicts prognosis following neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery 162(4):752-765, 2017. e-Pub 2017. PMID: 28688518.
132. Patel SH, Kim BJ, Tzeng CD, Chun YS, Conrad C, Vauthey JN, Aloia TA. Reduction of cardiopulmonary/renal complications with serum BNP-guided volume status management in posthepatectomy patients. J Gastrointest Surg 22(3):467-476. e-Pub 2017. PMID: 29234998.
133. Yamashita S, Venkatesan AM, Mizuno T, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Remnant liver ischemia as a prognostic factor for cancer-specific Survival after resection of colorectal liver metastases. JAMA Surg 18(152):10, 2017. e-Pub 2017. PMID: 28854316.
134. Aloia TA, Kim BJ, Chun YS, Cata JP, Truty MJ, Shi Q, Holmes A, Soliz JM, Popat KU, Rahlfs TF, Lee JE, Wang XS, Morris JS, Gottumukkala VNR, Vauthey JN. A randomized controlled trial of postoperative thoracic epidural analgesia versus intravenous patient-controlled analgesia after major hepatopancreatobiliary surgery. Ann Surg 266(3):545-554, 2017. e-Pub 2017.
135. Vinuela E, Vega EA, Yamashita S, Sanhueza M, Mege R, Cavada G, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Incidental gallbladder cancer: Residual cancer discovered at oncologic extended resection determines outcome: A report from high- and low-Incidence countries. Ann Surg Oncol 24(8):2334-2343, 2017. e-Pub 2017. PMID: 28417239.
136. Odisio BC, Yamashita S, Frota L, Huang SY, Kopetz SE, Ahrar K, Chun YS, Aloia TA, Hicks ME, Gupta S, Vauthey JN. Planned treatment of advanced metastatic disease with completion ablation after hepatic resection. J Gastrointest Surg 21(4):628-635, 2017. e-Pub 2017. PMID: 27882510.
137. Yamashita S, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases. J Hepatol 67(1):56-64, 2017. e-Pub 2017. PMID: 28192187.
138. Vega EA, Yamashita S, Chun YS, Kim M, Fleming JB, Katz MH, Tzeng CW, Raghav KP, Vauthey JN, Lee JE, Conrad C. Effective laparoscopic management lymph node dissection for gallbladder cancer. Ann Surg Oncol 24(7):1852, 2017. e-Pub 2017. PMID: 28168387.
139. Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural history of T1N0M0 hepatocellular carcinoma: large-scale study in the United States. Oncology 93(4):233-242. e-Pub 2017. PMID: 28683459.
140. Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, Koay EJ. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol 4:39-45, 2017. e-Pub 2017.
141. Yamashita S, Odisio BC, Huang SY, Kopetz SE, Ahrar K, Chun YS, Conrad C, Aloia TA, Gupta S, Harmoush S, Hicks ME, Vauthey JN. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases. Eur J Surg Oncol 43(6):1040-1049, 2017. e-Pub 2017. PMID: 28187878.
142. Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, Koay EJ. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol 4:39-45, 2017. e-Pub 2017. PMID: 29594206.
143. Kutlu OC, Chan JA, Aloia TA, Chun YS, Kaseb AO, Passot G, Yamashita S, Vauthey JN, Conrad C. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. Cancer 123(10):1817-1827, 2017. e-Pub 2017. PMID: 28085184.
144. Odisio BC, Yamashita S, Huang SY, Harmoush S, Kopetz SE, Ahrar K, Chun YS, Conrad C, Aloia TA, Gupta S, Hicks ME, Vauthey JN. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg 104(6):760-768, 2017. e-Pub 2017.
145. Yamashita S, Loyer E, Kang HC, Aloia TA, Chun YS, Mehran RJ, Eng C, Lee JE, Vauthey JN, Conrad C. Total transthoracic approach facilitates laparoscopic hepatic resection in patients with significant prior abdominal surgery. Ann Surg Oncol 24(5):1376-1377, 2017. e-Pub 2017. PMID: 27878479.
146. Yamashita S, Koay EJ, Passot G, Shroff R, Raghav KP, Conrad C, Chun YS, Aloia TA, Tao R, Kaseb A, Javle M, Crane CH, Vauthey JN. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients. Cancer 123(8):1354-1362, 2017. e-Pub 2017. PMID: 27984655.
147. Yamashita S, Koay EJ, Passot G, Shroff R, Raghav KP, Conrad C, Chun YS, Aloia TA, Tao R, Kaseb A, Javle M, Crane CH, Vauthey JN. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients. Cancer 123(8):1354-1362, 2017. e-Pub 2017.
148. Mizuno T, Sheth R, Yamamoto M, Kang HS, Yamashita S, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Laparoscopic Glissonean pedicle transection (TAKASAKI) for negative fluorescent counterstaining of segment 6. Ann Surg Oncol 24(4):1046-1047, 2017. e-Pub 2017. PMID: 27995453.
149. Yamashita S, Passot G, Aloia TA, Chun YS, Javle M, Lee JE, Vauthey JN, Conrad C. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer. Br J Surg 104(3):267-277, 2017. e-Pub 2017. PMID: 28052308.
150. Passot G, Denbo JW, Yamashita S, Kopetz SE, Chun YS, Maru D, Overman MJ, Brudvik KW, Conrad C, Aloia TA, Vauthey JN. Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection. Surgery 161(2):332-340, 2017. e-Pub 2017. PMID: 27592215.
151. Denbo JW, Yamashita S, Passot G, Egger M, Chun YS, Kopetz SE, Maru D, Brudvik KW, Wei SH, Conrad C, Vauthey JN, Aloia TA. RAS mutation is associated with decreased survival in patients undergoing repeat hepatectomy for colorectal liver metastases. J Gastrointest Surg 21(1):68-77, 2017. e-Pub 2017. PMID: 27334313.
152. Yamashita S, Loyer E, Chun YS, Javle M, Lee JE, Vauthey JN, Conrad C. Laparoscopic management of gallbladder cancer: A stepwise approach. Ann Surg Oncol 23(Suppl 5):892-893, 2016. e-Pub 2016. PMID: 27456958.
153. Yamashita S, Vauthey JN, Kaseb AO, Aloia TA, Conrad C, Hassan MM, Passot G, Raghav KP, Shama MA, Chun YS. Prognosis of fibrolamellar carcinoma compared to non-cirrhotic conventional hepatocellular carcinoma. J Gastrointest Surg 20(10):1725-31, 2016. e-Pub 2016. PMID: 27456016.
154. Passot G, Chun YS, Kopetz SE, Overman MJ, Conrad C, Aloia TA, Vauthey JN. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations. Eur J Surg Oncol 42(9):1378-84, 2016. e-Pub 2016.
155. Passot G, Chun YS, Kopetz SE, Overman MJ, Conrad C, Aloia TA, Vauthey JN. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations. Eur J Surg Oncol 42(9):1378-84, 2016. e-Pub 2016. PMID: 27358198.
156. Brudvik KW, Mise Y, Chung MH, Chun YS, Kopetz SE, Passot G, Conrad C, Maru DM, Aloia TA, Vauthey JN. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol 23(8):2635-43, 2016. e-Pub 2016. PMID: 27016292.
157. Brudvik K, Mise Y, Chung MH, Chun YS, Kopetz SE, Passot G, Conrad C, Maru D, Aloia TA, Vauthey JN. RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol 23(8):2635-43, 2016. e-Pub 2016.
158. Passot G, Chun YS, Kopetz SE, Zorzi D, Brudvik KW, Kim BJ, Conrad C, Aloia TA, Vauthey JN. Predictors of safety and efficacy of 2-stage hepatectomy for bilateral colorectal liver metastases. J Am Coll Surg 223(1):99-108, 2016. e-Pub 2016.
159. Passot G, Chun YS, Kopetz SE, Zorzi D, Brudvik KW, Kim BJ, Conrad C, Aloia TA, Vauthey JN. Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases. J Am Coll Surg 223(1):99-108, 2016. e-Pub 2016. PMID: 26968325.
160. Conrad C, Passot G, Katz MH, Fleming JB, Kim M, Chun YS, Aloia TA, Vauthey JN, Lee JE. Laparoscopic insulinoma enucleation from the retro-pancreatic neck: A stepwise approach. Ann Surg Oncol 23(6):2001, 2016. e-Pub 2016. PMID: 26960928.
161. Passot G, Odisio BC, Zorzi D, Mahvash A, Gupta S, Wallace MJ, Kim BJ, Yamashita S, Conrad C, Aloia TA, Vauthey JN, Chun YS. Eradication of missing liver metastases after fiducial placement. J Gastrointest Surg 20(6):1173-8, 2016. e-Pub 2016. PMID: 26791387.
162. Day RW, Brudvik KW, Vauthey JN, Conrad C, Gottumukkala V, Chun YS, Katz MH, Fleming JB, Lee JE, Aloia TA. Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. Surgery 159(3):793-801, 2016. e-Pub 2016. PMID: 26584854.
163. Chun YS, Parker RJ, Inampudi S, Ehrenwald E, Batts KP, Burgart LJ, Schumacher CW, Mehling JA, Engstrom BI, Hill MJ, Reddy SK, Sielaff TD. Imaging surveillance of hypervascular liver lesions in non-cirrhotic patients. J Gastrointest Surg 20(3):564-7, 2016. e-Pub 2016. PMID: 26376993.
164. Fang S, Wang Y, Chun YS, Liu H, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Schacherer CW, Reveille JD, Chen W, Sui D, Bassett RL, Wang LE, Wei Q, Amos CI, Lee JE. Association of common genetic polymorphisms with melanoma patient il-12p40 blood levels, risk, and outcomes. J Invest Dermatol 135(9):2266-2272, 2015. e-Pub 2015.
165. Fang S, Wang Y, Chun YS, Liu H, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Schacherer CW, Reveille JD, Chen W, Sui D, Bassett RL, Wang LE, Wei Q, Amos CI, Lee JE. Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. J Invest Dermatol 135(9):2266-2272, 2015. e-Pub 2015. PMID: 25848976.
166. Fang S, Wang Y, Chun YS, Liu H, Ross MI, Gershenwald JE, Cormier JN, Royal RE, Lucci A, Schacherer CW, Reveille JD, Sui D, Bassett RL, Wang LE, Wei Q, Amos CI, Lee JE. The relationship between blood IL-12p40 level and melanoma progression. Int J Cancer 136(8):1874-80, 2015. e-Pub 2015. PMID: 25196740.
167. Chun YS, Huang M, Rink L, Von Mehren M. Expression levels of insulin-like growth factors and receptors in hepatocellular carcinoma: a retrospective study. World J Surg Oncol 22(12):231, 2014. e-Pub 2014. PMID: 25052889.
168. Papavasiliou P, Hoffman JP, Cohen SJ, Meyer JE, Watson JC, Chun YS. Impact of preoperative therapy on patterns of recurrence in pancreatic cancer. HPB (Oxford) 16(1):34-9, 2014. e-Pub 2014. PMID: 23458131.
169. Thomay AA, Nagorney DM, Cohen SJ, Sigurdson ER, Truty MJ, Burtness B, Hall MJ, Chun YS. Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage IV colorectal cancer. J Gastrointest Surg 18(1):69-74, 2014. e-Pub 2014. PMID: 24002765.
170. Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 30(36):4566-72, 2012. e-Pub 2012. PMID: 23150701.
171. Papavasiliou P, Arrangoiz R, Zhu F, Chun YS, Edwards K, Hoffman JP. The anatomic course of the first jejunal branch of the superior mesenteric vein in relation to the superior mesenteric artery. Int J Surg Oncol(2090-1402):538769, 2012. e-Pub 2012.
172. Chun YS, Cooper HS, Cohen SJ, Konski A, Burtness B, Denlinger CS, Astsaturov I, Hall MJ, Hoffman JP. Significance of pathologic response to preoperative therapy in pancreatic cancer. Ann Surg Oncol 18(13):3601-7, 2011. e-Pub 2011. PMID: 21947697.
173. Adusumilli PS, Gholami S, Chun YS, Mullerad M, Chan MK, Yu Z, Ben-Porat L, Rusch VW, Fong Y. Fluorescence-assisted cytological testing (FACT): Ex Vivo viral method for enhancing detection of rare cancer cells in body fluids. Mol Med 17(7-8):628-34, 2011. e-Pub 2011. PMID: 21487639.
174. Chun YS, Milestone BN, Watson JC, Cohen SJ, Burtness B, Engstrom PF, Haluszka O, Tokar JL, Hall MJ, Denlinger CS, Astsaturov I, Hoffman JP. Defining venous involvement in borderline resectable pancreatic cancer. Ann Surg Oncol 17(11):2832-8, 2010. e-Pub 2010. PMID: 20725860.
175. Maru DM, Kopetz S, Boonsirikamchai P, Agarwal A, Chun YS, Wang H, Abdalla EK, Kaur H, Charnsangavej C, Vauthey JN, Loyer EM. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol 34(9):1287-94, 2010. e-Pub 2010. PMID: 20697255.
176. Palavecino M, Kishi Y, Chun YS, Brown DL, Gottumukkala VN, Lichtiger B, Curley SA, Abdalla EK, Vauthey JN. Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery 147(1):40-8, 2010. e-Pub 2010. PMID: 19733879.
177. Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, Curley SA, Abdalla EK, Kaur H, Charnsangavej C, Loyer EM. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302(21):2338-44, 2009. e-Pub 2009. PMID: 19952320.
178. Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, Curley SA, Vauthey JN. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 250(4):540-8, 2009. e-Pub 2009. PMID: 19730239.
179. Palavecino M, Chun YS, Madoff DC, Zorzi D, Kishi Y, Kaseb AO, Curley SA, Abdalla EK, Vauthey JN. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. Surgery 145(4):399-405, 2009. e-Pub 2009. PMID: 19303988.
180. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16(3):614-22, 2009. e-Pub 2009. PMID: 19130139.
181. Blazer DG, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JN. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26(33):5344-51, 2008. e-Pub 2008. PMID: 18936472.
182. Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Chun YS, Vauthey JN. Is embolization of segment 4 portal veins before extended right hepatectomy justified?. Surgery 144(5):744-51, 2008. e-Pub 2008. PMID: 19081016.
183. Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol 15(10):2765-72, 2008. e-Pub 2008. PMID: 18636296.
184. Woo Y, Kelly KJ, Stanford MM, Galanis C, Chun YS, Fong Y, McFadden G. Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells. Ann Surg Oncol 15(8):2329-35, 2008. e-Pub 2008. PMID: 18454298.
185. Riedl CC, Brader P, Zanzonico PB, Chun YS, Woo Y, Singh P, Carlin S, Wen B, Ling CC, Hricak H, Fong Y. Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET. Radiology 248(2):561-70, 2008. e-Pub 2008. PMID: 18641253.
186. Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM, Wei SH, Vauthey JN. Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg 12(1):123-8, 2008. e-Pub 2008. PMID: 17924174.
187. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11(11):1498-504; discussion 1504-5, 2007. e-Pub 2007. PMID: 17849166.
188. Iqbal CW, Chun YS, Farley DR. Colonoscopic perforations: a retrospective review. J Gastrointest Surg 9(9):1229-35: discussion 1236, 2005. e-Pub 2005. PMID: 16332478.
189. Adusumilli PS, Eisenberg DP, Chun YS, Ryu KW, Ben-Porat L, Hendershott KJ, Chan MK, Huq R, Riedl CC, Fong Y. Virally directed fluorescent imaging improves diagnostic sensitivity in the detection of minimal residual disease after potentially curative cytoreductive surgery. J Gastrointest Surg 9(8):1138-46; discussion 1146-7, 2005. e-Pub 2005. PMID: 16269385.
190. Hamghalam M, Peoples JJ, Kobayashi K, Park G, Kwak E, Bunker EC, Gangai N, Gonen M, Chun YS, Kang HC, Do RK, Simpson AL. Liver cancer segmentator: Metadata-guided confidence scoring for reliable segmentation of colorectal liver metastases in CT.

Invited Articles

1. Passot G, Vauthey JN, Chun YS. ASO author reflections: RAS mutations in metastatic colorectal cancer. Ann Surg Oncol 25(Suppl 3):850-851, 2018. e-Pub 2018. PMID: 30421059.
2. Lee AJ, Chun YS. Intrahepatic Cholangiocarcinoma: The AJCC/UICC 8th Edition Updates. Chin Clin Oncol 7(5):52, 2018. e-Pub 2018. PMID: 30180751.
3. Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol 25(4):845-847, 2018. e-Pub 2018. PMID: 28752469.
4. Lam M, Loree JM, Pereira AAL, Chun YS, Kopetz S. Accelerating therapeutic development through innovative trial design in colorectal cancer. Curr Treat Options Oncol 19(2):11, 2018. e-Pub 2018. PMID: 29488033.
5. Chun YS. Role of radical antegrade modular pancreatosplenectomy (RAMPS) and pancreatic cancer. Ann Surg Onc 25(1):46-50, 2018. e-Pub 2018. PMID: 27848048.
6. Chun YS, Javle M. Systemic and adjuvant therapies for intrahepatic cholangiocarcinoma. Cancer Control 24(3):1-7, 2017. e-Pub 2017. PMID: 28975832.
7. Torzilli G, Nagino M, Tzeng CW, Kingham TP, Alatise OI, Ayandipo B, Yamashita S, Arrington AK, Kim J, Chun YS, Vauthey JN. SSAT state-of-the-art conference: new frontiers in liver surgery. J Gastrointest Surg 21(1):175-185, 2017. e-Pub 2017. PMID: 27480411.
8. Shindoh J, Chun YS, Loyer EM, Vauthey JN. Non-size-based response criteria to preoperative chemotherapy in patients with colorectal liver metastases: the morphologic response criteria. Curr Colorectal Cancer Rep 9(2):198-202, 2013. e-Pub 2013. PMID: 23710157.
9. Papavasiliou P, Chun YS, Hoffman JP. How to define and manage borderline resectable pancreatic cancer. Surg Clin North Am 93(3):663-674, 2013. e-Pub 2013. PMID: 23632151.
10. Chun YS, House MG, Kaur H, Loyer EM, Paradis V, Vauthey JN. SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions. J Gastrointest Surg 17(4):636-44, 2013. e-Pub 2013. PMID: 23377783.
11. Abdalla EK, Bauer TW, Chun YS, D'Angelica M, Kooby DA, Jarnagin WR. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements. HPB (Oxford) 15(2):119-30, 2013. e-Pub 2013.
12. Chun YS, Zimmitti G. Fibrolamellar variant of hepatocellular carcinoma. Recent Results Cancer Res 190:101-110, 2013. e-Pub 2013. PMID: 22941016.
13. Chun YS, Laurent A, Maru D, Vauthey JN. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 10(3):278-86, 2009. e-Pub 2009. PMID: 19261256.
14. Chun YS, Vauthey JN. Risks of neoadjuvant chemotherapy for resectable colorectal carcinoma hepatic metastases. Curr Colorectal Cancer Rep(4):87-92, 2008. e-Pub 2008.
15. Ribero D, Chun YS, Vauthey JN. Standardized liver volumetry for portal vein embolization. Semin Intervent Radiol 25(2):104-9, 2008. e-Pub 2008. PMID: 21326551.
16. Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, Bhoori S, Lee SG. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol 15(4):1001-7, 2008. e-Pub 2008.
17. Chun YS Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 33 Suppl 2:S52-8, 2007. e-Pub 2007. PMID: 18006265.

Review Articles

1. Haddad A, Lendoire M, Ito K, Ayabe RI, Maki H, Pietz JT, Stucky CH, Tzeng CD, Cao HST, Chun YS, Newhook TE, Hallet J, Vauthey JN. Ergonomic Considerations in Open Liver Surgery. J Gastrointest Surg:102241, 2025. e-Pub 2025. PMID: 41038338.
2. Maki H, Jain AJ, Haddad A, Lendoire M, Chun YS, Vauthey JN. Locoregional treatment for colorectal liver metastases aiming for precision medicine. Ann Gastroenterol Surg 7(4):543-552, 2023. e-Pub 2023. PMID: 37416742.
3. Chun YS, Adusumilli PS, Fong Y. Employing tumor hypoxia for oncolytic therapy in breast cancer. J Mammary Gland Biol Neoplasia 10(4):311-8, 2005. e-Pub 2005. PMID: 16826462.
4. Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ, Donohue JH. Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?. Cancer 92(1):181-7, 2001. e-Pub 2001. PMID: 11443625.

Professional Educational Materials

1. Parikh A, White S, Hogg M, Chun YS. Primary and metastatic liver cancer. Society of Surgical Oncology/Society of Interventional Oncology Joint Virtual Tumor Board, 2022.
2. Hawn MT, Kate V, Chun YS. Surgical Clinical Trials: Potential Pitfalls and Solutions. SSAT Research Grant Writing Workshop Webinar Series, 2021.

Other Articles

1. Lam M, Loree JM, Pereira AAL, Chun YS, Kopetz S Correction to: Accelerating Therapeutic Development through Innovative Trial Design in Colorectal Cancer. Curr Treat Options Oncol 19(5):25, 2018. PMID: 29687230.
2. Chun YS, Calderaro J, Zucman-Rossi J Synchronous hepatocellular carcinoma and Castleman's disease: the role of the interleukin-6-signaling pathway. Hepatology 56(1):392-3, 2012. PMID: 22611056.
3. Chun YS, Robu VG Spectrum of primary vascular neoplasms of the spleen. J Clin Oncol 29(5):e116-7, 2011. PMID: 21115874.
4. Chun YS, Cherry KJ Radiation arteritis. J Am Coll Surg 196(3):482, 2003. PMID: 12648702.

Editorials

1. Kawaguchi Y, Jain AJ, Chun YS, Vauthey JN. Artificial Intelligence or Tumor Biology to Predict Survival After Resection of Colorectal Liver Metastases?. Ann Surg Oncol. PMID: 36809607.
2. Newhook TE, Chun YS, Vauthey JN. An odyssey into the land of deleterious rare mutations in colorectal liver metastases. Ann Surg Oncol 27(9):3115-3117, 2020. PMID: 32651694.
3. Chun YS, D'Angelica M. Colorectal cancer: a multifaceted disease. Chinese Clinical Oncology 8(5):45, 2019. PMID: 31597433.
4. Chun YS, Vauthey JN. Local therapy for colorectal liver metastases: Establishing today's level of evidence and defining tomorrow's roadmap. J Natl Cancer Inst(109):9, 2017. PMID: 28376150.

Abstracts

1. Witt R, Traweek R, Arvide E, Nguyen S, Ikoma N, Newhook T, Tzeng CW Chun YS, Vauthey JN, Tran Cao H. Opioid reduction following minimally invasive liver surgery: aiming beyond incision size. SSAT 162(7), 2022. e-Pub 2022.
2. Vega E, Newhook T, Ruzzenente A, Okuno M, De Bellis M, Mellado S, Panettieri E, De Rose A, Nishino H, Chun YS, Tran Cao H, Tzeng CW, Aretxabala X, Seo S, Giulilante F, Guglielmi A, Vinuela E, Vauthey JN. Benchmark analysis: multi-institutional cooperative cohort for gallbladder cancer surgery. SSAT 162(7), 2022. e-Pub 2022.
3. Vreeland T, Kim B, Kawaguchi Y, Perez-Arango N, Panettieri E, Newhook T, Baumann D, Santos D, Chun YS, Tzeng CW, Aloia T, Vauthey, JN. Incidence of and risk factors for incisional hernia after open hepatectomy for colorectal liver metastases. SSAT 162(7), 2022. e-Pub 2022.
4. Kothari A, Nishioka Y Arvide E, Cristo J, Wei S, Newhook T, Tran Cao H, Tzeng CW, Chun YS, Lee J, Vauthey JN. Real world data supports post-pandemic continuation of telemedicine surveillance visits following resection of colorectal liver metastases. SSAT 162(7), 2022. e-Pub 2022.
5. Martin A, Maki H, Arvide E, Dewhurst W, Phan T, Newhook T, Tran Cao H, Chun YS, Tzeng CW, Vauthey JN. Safety and outcomes of repeated liver resection for colorectal liver metastases: a review of 23 years of hepatectomy data. SSAT 162(7), 2022. e-Pub 2022.
6. Kim B, Panettieri E, Kawaguchi Y, Ardito F, Mele C, De Rose A, Vellone M, Newhook T, Tran Cao H, Chun YS, Tzeng CW, Giulilante F, Vauthey JN. Survival outcome of two or more resections of recurrence with or without extrahepatic disease after first curative resection for colorectal liver metastases. SSAT 162(7), 2022. e-Pub 2022.
7. Mason M, Krasnodębski M, Barker C, Nishioka Y, Kothari A, Chiang YJ, Newhook T, Tzeng CW, Chun YS, Aloia T, Vauthey JN, Tran Cao H. Outcomes of mixed pathologic response in patients with multiple colorectal liver metastases treated with neoadjuvant chemotherapy and liver resection. SSAT Annual 2021 160(6), 2021. e-Pub 2021.
8. Arango N, Nishioka Y, Kawaguchi Y, Boettcher F, Newhook T, Chun YS, Aloia T, Tzeng CW, Tran Cao H, Lee J, Vreeland T, Vauthey JN. Neither surgical margin status nor somatic mutation predicts local recurrence after r0-intent resection for colorectal liver metastases. SSAT Annual 2021 160(6), 2021. e-Pub 2021.
9. Swords D, Newhook T, Tzeng CW, Chun YS, Aloia T, Kaseb A, Vauthey JN, Tran Cao H. Disparities in use of surgical treatments mediate half of socioeconomic survival disparities in stage i-ii hepatocellular carcinoma. SSAT 160(6), 2021. e-Pub 2021.
10. Kim B, Arvide E, Kawaguchi Y, Dewhurst W, Phan T, Tran Cao H, Aloia T, Chun YS, Katz M, Vauthey JN, Tzeng CW, Newhook T. Utilization of the kawaguchi-gayet complexity classification to create, implement, and validate risk-stratified post-hepatectomy pathways based on anticipated length of stay. SSAT Annual 2021 160(6), 2021. e-Pub 2021.
11. Kothari A, Hester C, Tzeng CW, Newhook T, Chun YS, Thomas A, Vauthey JN, Tran Cao H. Survival in patients with colorectal liver metastases is associated with multimodality capacity of the treating facility. SSAT Annual 2021 160(6), 2021. e-Pub 2021.
12. Gaskill C, Kim B, Newhook T, Arvide E, Dewhurst W, Phan T, Cristo J, Tran Cao H, Aloia T, Chun YS, Vauthey, JN, Tzeng CW. Every drop matters: intraoperative fluids during hepatectomy and postoperative ileus. SSAT Annual 2021 160(6), 2021. e-Pub 2021.
13. Kaseb AO, Tran Cao H, Mohamed YI, Qayyum A, Vence LM, Blando JM, Singh S, Lee SS, Raghav KP, Altameemi L, Rashid A, Vauthey JN, Carter K, Tzeng CWT, Chun YS, Yao JC, Wolff RA, Allison JP, Sharma P. Final results of a randomized, open label, perioperative phase II study evaluating nivolumab alone or nivolumab plus ipilimumab in patients with resectable HCC. ASCO Annual 38(15), 2020. e-Pub 2020.
14. Kawaguchi Y, Newhook TE, Vreeland TJ, Tran Cao H, Tzeng CW, Aloia TA, Chun YS, Vauthey JN. Alteration of FBXW7 is associated with worse survival in patients undergoing resection of colorectal liver metastases. SSAT Annual 2020 61, 2020. e-Pub 2020.
15. Day RW, Newhook TE, Dewhurst W, Arvide E, Bruno M, Kim M, Tran Cao H, Ikoma N, Chun YS, Aloia TA, Katz MH, Lee JE, Vauthey JN, Tzeng CW. Patient-specific opioid volume calculations reduce discharge prescriptions after hepatopancreato-biliary surgery. 2020 AHPBA Annual, 2020. e-Pub 2020.
16. Kim BJ, Tzeng CW, Ikoma N, Chiang YJ, Chun YS, Aloia TA, Vauthey JN, Tran Cao H. Minimally invasive approaches to biliary tract cancers and nodal sampling: not all approaches are similar. 2020 AHPBA Annual, 2020. e-Pub 2020.
17. Kim BJ, Gaskill C, Newhook TE, Arvide E, Dewhurst WL, Tran Cao H, Chun YS, Aloia TA, Vauthey JN, Tzeng CW. Utilization of the Kawaguchi-Gayet complexity classification to stratify hepatectomy patients for distinct enhanced recovery pathways based on anticipated length of stay. 2020 AHPBA Annual, 2020. e-Pub 2020.
18. Vicente D, Mizuno T, Loehrer A, Limani P, Royal RE, Fournier K, Chun YS, Conrad C, Tzeng C, Kopetz S, Aloia T, Vauthey J. SMAD4 gene mutation is associated with higher incidence of peritoneal involvement in unresectable metastatic colorectal cancer. Ann Surg Oncol 25(Suppl. 1):S166, 2018. e-Pub 2018.
19. Simoneau E, Chun YS, Karpinets T, Zhan J, Song X, Javle M, Shroff R, Futreal A, Vauthey JN, Estrella J. Genomic profiling of intrahepatic metastases versus localized satellites in intrahepatic cholangiocarcinoma. Ann Surg Oncol 25(Suppl 1):S24, 2018. e-Pub 2018.
20. Goumard C, You Y, Okuno M, Vega Pizzaro EA, Simoneau E, Aloia T, Chun YS, Tzeng C, Raghav K, Vauthey J, Conrad C. Impact of postoperative complications on return to intended oncologic treatment and survival in patients undergoing resection for rectal cancer with synchronous liver metastases. Ann Surg Oncol 25(Suppl. 1):S135, 2018. e-Pub 2018.
21. Kim B, Denbo J, Davis C, Chun YS, Vauthey JN, Tzeng CW, Aloia T. For patients with hepatocellular carcinoma, perioperative transfusion is a co-variate for short-term morbidity and mortality but does not impact long-term oncologic outcomes. Gastroenterology 152(5):S1255, 2017. e-Pub 2017.
22. Cloyd JM, Chun YS, Denbo J, Javle M, Shroff R, Vauthey JN, Aloia T, Cuddy A, Rodriguez-Bigas MA, You N. Long-term survival among mismatch repair deficient cholangiocarcinomas associated with lynch syndrome. Gastroenterology 152(Supp 1):5: S-1254, 2017. e-Pub 2017.
23. Denbo J, Kim B, Vauthey J, Conrad C, Ma J, Chun YS, Katz M, Aloia T. Overall body composition and sarcopenia are associated with poor liver regeneration following portal vein embolization. HPB 19(Suppl 1):S20, 2017. e-Pub 2017.
24. Mizuno T, Sheth R, Yamamoto M, Kang H, Yamashita S, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Laparoscopic glissonean pedicle transection method (TAKASAKI) for negative fluorescent counterstaining of segment 6. HPB 19:S114, 2017. e-Pub 2017.
25. Cloyd J, Tzeng C, Mizuno T, Conrad C, Omichi K, Aloia T, Vauthey J, Chun YS. BRAF mutation is not a contraindication to resection of colorectal liver metastases. HPB 19:S55-S56, 2017. e-Pub 2017.
26. Patel S, Kim B, Tzeng C, Chun YS, Conrad C, Vauthey J, Aloia T. Reduction of cardiopulmonary/renal complications with serum brain natriuretic peptide-guided volume status management in post hepatectomy patients. HPB 19:S29, 2017. e-Pub 2017.
27. Yamashita S, Omichi K, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CWD. Portal vein embolization reduces postoperative hepatic insufficiency associated with hepatic atrophy caused by extensive chemotherapy. Gastroenterology 152(Supp 1):5, 2017. e-Pub 2017.
28. Chun YS, Mehran RJ, Tzeng CW, Kee BK, Dasari A, Sepesi B, Conrad C, Aloia TA, Kopetz SE, Vauthey JN. LUNA: A randomized phase II trial of liver resection plus chemotherapy or chemotherapy alone in patients with unresectable lung and resectable liver metastases from colorectal adenocarcinoma. J Clin Oncol 35(15 suppl):TPS3625, 2017. e-Pub 2017.
29. Amer AM, Tao R, Kang H, Chun YS, Vauthey JN, Javle MM, Kaseb AO, Crane CH, Koay EJ. Quantitative european association for the study of the liver (qEASL) as an early biomarker of response after radiation therapy for intrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 96(2S):S202, 2016. e-Pub 2016. PMID: 27675783.
30. Conrad C, Passot G, Katz MHG, Fleming JB, Kim MP, Chun YS, Aloia TA, Vauthey JN, Lee JE. Laparoscopic insulinoma enucleation from the retro-pancreatic neck: A stepwise approach. Ann Surg Oncol 23(6):2001, 2016. e-Pub 2016. PMID: 26960928.
31. Yamashita S, Chun YS, Passot G, Conrad C, Aloia TA, Shma MA, Raghav K, Hassan M, Kaseb A, Vauthey JN. Prognosis of fibrolamellar carcinoma compared to non-cirrhotic conventional hepatocellular carcinoma. Gastroenterology 150(Suppl. 1):S1188, 2016. e-Pub 2016.
32. Patel SH, Kim B, Chun YS, Conrad C, Vauthey JN, Aloia T. Serum brain natriuretic peptide in the perioperative management of volume status in patients post hepatectomy. HPB 18:e597-8, 2016. e-Pub 2016.
33. Phuoc V, Chun YS, Vauthey JN, Newhook T, Conrad C, Aloia TA, Kang H, Yedururi S, Loyer EM. Radiographic predictors of intrahepatic recurrence after resection of colorectal liver metastases. Ann Surg Oncol 23(Suppl. 1):S116, 2016. e-Pub 2016.
34. Denbo J, Passot G, Chun YS, Yamashita S, Kopetz S, Maru D, Brudvik KW, Wei S, Conrad C, Aloia T, Vauthey JN. RAS mutation status impacts survival in patients undergoing repeat hepatectomy for colorectal liver metastases. Gastroenterology 150(Suppl. 1):S1174, 2016. e-Pub 2016.
35. Conrad C, Weissinger D, Shiozaki H, Aloia TA, Bednarski B, Messick CA, Chun YS, Vauthey JN. Coordinated minimally invasive multi-stage surgery for stage IV colorectal cancer. Ann Surg Oncol 23(Suppl. 1):S110, 2016. e-Pub 2016.
36. Chun YS, Reddy SK, Leach J, Inampudi S, Ehrenwald E, Sielaff T. Synergistic effects of radioembolization and ipilimumab in metastatic melanoma to the liver. Gastroenterology 148:S-1181, 2015. e-Pub 2015.
37. Chun YS, Parker RJ, Reddy SK, Ehrenwald E, Hill MJ, Inampudi S, Sielaff TD. Imaging surveillance of hepatocellular adenomas. HPB 17(Suppl. 1):25, 2015. e-Pub 2015.
38. Thomay AA, Hoffman JP, Chun YS. Defining resection margins in pancreatic cancer after neoadjuvant chemoradiotherapy. Gastroenterology 142(Suppl. 1):S1062-S1063, 2012. e-Pub 2012.
39. Siripurapu V, Papavasiliou P, Denlinger CS, Hoffman JP, Chun YS. The AJCC staging system for hepatocelluar carcinoma predicts survival in medically treated western patients. HPB 13(Suppl. 1):64, 2011. e-Pub 2011.
40. Papavasiliou P, Arrangoiz R, Milestone BN, Hoffman JP, Chun YS. Computed tomographic assessment of resectability after neoadjuvant therapy in pancreatic cancer. Ann Surg Oncol 18(Suppl. 1):S83, 2011. e-Pub 2011.
41. Chun YS, Kopetz S, Palavecino M, Zorzi D, Curley SA, Abdalla EK, Vauthey JN. Proposal of new staging in advanced colorectal cancer. Ann Surg Oncol 16(Suppl. 1):28, 2009. e-Pub 2009.
42. Chun YS, Abdalla EK, Zorzi D, Breaux JA, Vauthey JN. Liver hanging maneuver improves the outcomes of complex right upper quadrant resections. HPB 11(Suppl. 1):76-77, 2009. e-Pub 2009.

Book Chapters

1. Chun YS, Huang SY. Assessment of Hepatic Function and Preoperative Hepatic Optimization. In: Shackelford's Surgery of the Alimentary Tract. 9. Elsevier, 2025.
2. Newton AD, Chun YS. History of treatment of colorectal liver metastases. In: Colorectal Liver Metastasis. Springer Nature, 2023.
3. Oppliger F, Foo WC, Chun YS. Multigene testing for prognostication and therapeutic actionability. In: Colorectal Liver Metastasis. Springer Nature, 2023.
4. Chun YS, Kawaguchi Y, Vauthey JN. Hepatic metastasis from colorectal cancer. In: Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 7th Edition. Elsevier, 2022.
5. Makawita S, Lee S, Chun YS, Roach MA, Koay EJ, Javle M. Biliary tract cancer. In: The MD Anderson Manual of Medical Oncology. McGraw Hill, LLC, 1-29, 2022.
6. Lacin S, Rashid A, Chun YS, Odisio BC, Koay EJ, Abdel-Wahab A, Kaseb AO. Hepatocellular carcinoma. In: Textbook of Gastrointestinal Oncology. Springer Cham, 207-234, 2019.
7. Katkhuda R, Chun YS. Intrahepatic cholangiocarcinoma: epidemiology and risk factors. In: Intrahepatic Cholangiocarcinoma: Diagnosis and Management. Springer, 1-10, 2019.
8. Nagorney DM, Pawlik TM, Chun YS, Ebata T, Vauthey JN. Perihilar bile ducts. In: AJCC Cancer Staging Manual, Eighth Edition. Springer International Publishing, 311-316, 2016.
9. Chun YS, Tsai S. Key question: distal pancreatectomy. In: Operative Standards for Cancer Surgery. Wolters Kluwer, 253-259, 2015.
10. Chun YS. Multidisciplinary management of recurrent colorectal cancer: potentially resectable/curable disease: liver. In: Cancers of the Colon and Rectum: A Multidisciplinary Approach to Diagnosis and Management. Demos Medical Publishing, 175-196, 2013.
11. Chun YS, Vauthey JN. History of major liver resections. In: Venous Embolization of the Liver: Radiologic and Surgical Practice. Springer-Verlag, 3-8, 2011.
12. Zorzi D, Chun YS, Vauthey JN. Liver resection of colorectal liver metastases. In: Malignant Liver Tumors, Current and Emerging Therapies, 3rd Edition. Wiley-Blackwell, 192-202, 2010.
13. Vauthey JN, Pawlik TM, Abdalla EK, Aloia TA, Boudreaux CS, Chun YS, Dixon E, Fong Y, Kooby D, Lauwers GY, Mayo MS, Nagorney DM, Lombardo KR, Taouli B, Washington MK, Wittenkind C, Wu TT, Zhu A. Hepatobiliary staging chapters. In: AJCC Cancer Staging Manual, Seventh Edition. Springer International Publishing, 191-249, 2010.
14. Ribero D, Chun YS, Vauthey JN. Surgery for colorectal metastases. In: Liver Metastases. Springer-Verlag, 25-38, 2009.
15. Kendrick ML, Chun YS, Christein JD, Sarr MG. Surgical palliation of pancreatic cancer. In: Pancreatic Cancer. Barlett Publishers, 435-446, 2005.
16. Ayabe R, Liu M, Chun YS, D'Angelica MI. Management of Tumors Metastatic to the Liver. In: Sabiston Textbook of Surgery: The Biologic Basis of Modern Surgical Practice, 22nd edition. Elsevier.
17. Chun Y, Huang S. Portal Venous Anatomy and Percutaneous Portal Vein Embolization. In: Safe Major Hepatectomy after Preoperative Liver Regeneration. Elsevier.

Letters to the Editor

1. Chun YS, Vauthey JN, Passot G. Detection and Oncologic Significance of Colorectal Liver Micrometastases: In Reply to Yin and colleagues. J Am Coll Surg 236: 534, 2023.
2. Kawaguchi Y, Newhook TE, Fuks D, Cao HST, Tzeng CD, Chun YS, Aloia TA, Gayet B, Vauthey JN. Comment on "Stratification of Major Hepatectomies According to Their Outcome Analysis of 2212 Consecutive Open Resections in Patients Without Cirrhosis". Ann Surg 276: e134-e135, 2022.
3. Chun YS, Vauthey JN. Response to Comment on "Deleterious Effect of RAS and Evolutionary High Risk TP53 Double Mutation in Colorectal Liver Metastases". Ann Surg 271: e16-e17, 2020.
4. Vega EA, Simoneau E, Tzeng CD, Odisio BC, Aloia TA, Chun YS, Vauthey JN. Letter to the Editor Regarding "ALPPS Improves Resectability Compared with Conventional Two-Stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis": When Innovation is Not Enough. Ann Surg.